BRCA Associated Cancers: Latest Predictive and Therapeutic Approaches
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 15 August 2024 | Viewed by 127
Special Issue Editor
Special Issue Information
Dear Colleagues,
It is a pleasure to be Guest Editor for the upcoming Cancers Special Issue “BRCA Associated Cancers: Latest Predictive and Therapeutic Approaches”. The role of BRCA testing in the identification of an individual’s overall risk of developing certain cancer types, such as breast, ovarian, prostate and pancreatic cancer is widely recognized.
A plethora of clinical studies have presented various contributing factors to the higher prevalence of BRCA mutations in a population subset, such as personal or family history, ethnic background and early onset of cancer, where BRCA testing is recommended, also contributing to the therapeutic efficacy that treatment schemes such as PARP inhibitors could offer. This Special Issue highlights the role of BRCA testing from early risk assessment to options for treatment management, with the latest results of ongoing clinical studies being presented, demonstrating the clinical potential of various treatment options for BRCA-associated tumours, while investigating factors that contribute to the therapeutic response with significant future clinical relevance if integrated into the current clinical guidelines.
Dr. Melpomeni Kalofonou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- BRCA
- ovarian cancer
- breast cancer
- prostate cancer
- pancreatic cancer
- genetics
- epigenetics
